SPI Pharma has appointed Scott Thomson as chief executive officer. Scott is a highly experienced international business executive in strategy development and execution, operational management, and innovation for Specialty Ingredients. He joins the company after 29 years with BASF.

During his tenure with BASF, Mr. Thomson held various leadership roles in both North America and Germany, including Senior VP of BASF’s Global Pharmaceutical Solutions Business. He most recently served as senior vice president, Care Chemicals Division, North America.

Mr. Thomson brings highly relevant Pharmaceutical Excipients and other Specialty Ingredients business experience, as well as a solid track record of developing businesses through high performance teams and strong customer partnerships to deliver innovative solutions to the market.

Headquartered in Wilmington, DE, SPI Pharma provides services for global pharmaceutical and nutritional companies in the manufacture and marketing of antacid actives, excipients, drug delivery systems for tablets and powders, taste-masked actives and vaccine adjuvants. SPI Pharma also specializes in drug development services.